Heart Rate Dynamics in Response to Upper-Extremity Function Test to Identify Irreversible Frailty After Invasive Therapy in Older Adults with Advanced Heart Disease
Heart Rate Dynamics in Response to Upper-Extremity Function Test to Identify Irreversible Frailty After Invasive Therapy in Older Adults with Advanced Heart Disease
批准号:
10582957
负责人:
Nima Toosizadeh
金额:
$1.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-01-15 至 2023-06-30
关键词:
Adverse eventAgeAortic Valve StenosisArizonaAssessment toolBedsBehaviorBiomedical EngineeringBiometryCardiacCardiologyCardiopulmonaryCardiovascular systemCategoriesCause of DeathCharacteristicsChestClinicalClinical TreatmentCognitiveDataDiseaseElbowElderlyElectrocardiogramEngineeringEnvironmentExerciseEyeFatigueGeriatricsGoalsHealthcareHeartHeart DiseasesHeart RateHomeostasisInpatientsLassoLeadLeftLegal patentMachine LearningMeasuresMethodsMissionModelingMorphologic artifactsMotionMotorOutcomeParticipantPatientsPerformancePhysical activityPhysiologicalPrediction of Response to TherapyProceduresRecoveryReplacement TherapyResearchRiskRisk AssessmentSamplingSideSpeedStressSymptomsSystemTestingTherapeuticTrainingTreatment CostTreatment outcomeUnited StatesUniversitiesUpper ExtremityVascular blood supplyWalkingadverse outcomeaggressive therapyaortic valve replacementarmcandidate identificationcandidate selectionclinical carecommon treatmentcomorbiditycomparison controlcostdesignflexibilityfollow-upfrailtyheart functionheart rate monitorimprovedmotion sensormotor disordermotor impairmentmultidisciplinarymultimodalitynoveloutcome predictionpredict clinical outcomeprogramsresilienceresponserisk stratificationsensorsexsignal processingstressortherapy outcometoolwearable sensor technology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Advanced heart diseases lead to a reduced blood supply from the heart and consequently fatigue and deficits in
performing physical activity. In the proposed research, we will assess the lack of physiological reserve in older
adults with advanced heart disease, focusing on motor and cardiac function, to develop a novel, objective, quick,
and accurate frailty score. We designed this approach to enhance candidate selection of older adults going
through invasive therapies for advanced heart diseases. Although our approach is generic, to reduce between-
subject variability we focus on transcatheter aortic valve replacement (TAVR) for older adult with aortic stenosis.
Therapeutic options continue to grow for TAVR; however, it can be difficult to identify candidates with frailty level
that prohibit them from tolerating the stress from aggressive therapy and those with potential reversible frailty. It
is thus critically important to introduce meaningful routine objective frailty assessment into clinical care of cardiac
patients. Frailty assessment is, however, not common in cardiology because current assessment tools are
burdensome for older adults with advanced heart disease and impractical to implement in busy clinical
environments. More importantly, no disease-specific tool is available to identify heart disease-related frailty.
In continuation of our research program in the field of sensor-based frailty assessment, within our
multidisciplinary team of engineers, cardiologists, and geriatricians, we propose the multimodal upper-extremity
function (UEF) test for identifying frailty among older adults with advanced heart disease. UEF incorporates a
synchronized system of motion sensors and electrocardiography (ECG) to measure motor performance and
heart rate (HR) during a rapid 20-second elbow flexion task. Using our previously established UEF motion
tracking component, we can precisely measure the level of deficits in motor performance (slowness, weakness,
inflexibility, and fatigue), which are not detectable using eyeball assessment. Using the ECG setup, minimizing
the motion artifact using this localized task, we accurately track HR response to the physical demand, as well as
recovery behavior after the task. HR behavior during the task and recovery (HR dynamics) provide a measure
of cardiac reserve associated with frailty in heart disease. We will further quantify dysregulation between HR
response and motor demand as a novel measure of resilience. Based on our preliminary data, we expect a
weaker and delayed HR response to physical activity as well as an impaired motor function due to frailty.
The proposed research will be a four-year study at the University of Arizona Cardiovascular program. In the first
arm, we will establish a new HR score and merge it with our previously validated UEF motor score to develop a
multimodal frailty score among older adults with advanced heart disease (n=120). In the second arm, in a
longitudinally setting we will validate the UEF multimodal frailty score for predicting TAVR complications for
advanced heart disease (n=75). Accomplishing these aims, we will promote HR dynamic assessment for risk
stratification of older adults with advanced heart disease, with huge potentials for other comorbid conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: